JNK signaling pathway is involved in piperlongumine-mediated apoptosis in human colorectal cancer HCT116 cells

Oncology Letters

Volumn 10, Issue 2, 2015, Pages 709-715

  Li, Wen ^a,b,c   Wen, Chuangyu ^a,b   Bai, Haiyan ^d   Wang, Xiaoyan ^a,b   Zhang, Xiaoli ^a   Huang, Lanlan ^a,b   Yang, Xiangling ^a,b   Iwamoto, Aikichi ^e   Liu, Huanliang ^a,b  

^a Guangdong Institute of Gastroenterology and The Sixth Affiliated Hospital   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; C Jun NH2 terminal kinases; Colorectal cancer; Phosphorylation; Piperlongumine; SP600125

Indexed keywords

ANTHRA [1, 9 CD] PYRAZOL 6 (2H) ONE; PIPERLONGUMINE; PLANT EXTRACT; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE ASSAY; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MTS ASSAY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84931336471     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3371     Document Type: Article

References (32)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64: 9-29, 2014.
2. Van Cutsem E, Köhne CH, Hitre E, et al: Cetuximab and chemotherapy as initial treatment for metastatic colorectal cance. N Engl J Med 360: 1408-1417, 2009.
3. Ham J, Babij C, Whitfield J, et al: A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14: 927-939, 1995.
4. Chatterjee A and Dutta CP: Alkaloids of Piper longum Linn. I. Structure and synthesis of piperlongumine and piperlonguminine. Tetrahedron 23: 1769-1781, 1967.
5. Bezerra DP, Pessoa C, de Moraes MO, Saker-Neto N, Silveira ER and Costa-Lotufo LV: Overview of the therapeutic potential of piplartine (piperlongumine). Eur J Pharm Sci 48: 453-463, 2013.
6. Han SS, Son DJ, Yun H, Kamberos NL and Janz S: Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro. Leuk Res 37: 146-154, 2013.
7. Liu JM, Pan F, Li L, et al: Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation. Biochem Biophys Res Commun 437: 87-93, 2013.
8. Raj L, Ide T, Gurkar AU, et al: Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475: 231-234, 2011.
9. Randhawa H, Kibble K, Zeng H, Moyer MP and Reindl KM: Activation of ERK signaling and induction of colon cancer cell death by piperlongumine. Toxicol In Vitro 27: 1626-1633, 2013.
10. Bezerra DP, Militão GC, de Castro FO, et al: Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways. Toxicol In Vitro 21: 1-8, 2007.
11. Kong EH, Kim YJ, Cho HJ, et al: Piplartine induces caspase-mediated apoptosis in PC-3 human prostate cancer cells. Oncol Rep 20: 785-792, 2008.
12. Wang Y, Wang JW, Xiao X, et al: Piperlongumine induces autophagy by targeting p38 signaling. Cell Death Dis 4: e824, 2013.
13. Shrivastava S, Kulkarni P, Thummuri D, et al: Piperlongumine, an alkaloid causes inhibition of PI3K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells. A Internat J Program Cell Death 19: 1148-1164, 2014.
14. Adams DJ, Dai M, Pellegrino G, et al: Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs. Proc Natl Acad Sci USA 109: 15115-15120, 2012.
15. Kim TH, Song J, Kim SH, et al: Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells. Neuro Oncol 16: 1354-1364, 2014.
16. Kyriakis JM and Avruch J: Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 92: 689-737, 2012.
17. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995.
18. Chang L and Karin M: Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001.
19. Hu R, Kim BR, Chen C, Hebbar V and Kong AN: The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 24: 1361-1367, 2003.
20. Xu C, Shen G, Yuan X, et al: ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 27: 437-445, 2006.
21. Wang T, Arifoglu P, Ronai Z and Tew KD: Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 276: 20999-21003, 2001.
22. Song M, Chen D, Lu B, et al: PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer. PLoS One 8: e65821, 2013.
23. Bennett BL, Sasaki DT, Murray BW, et al: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681-13686, 2001.
24. Fuchs SY, Dolan L, Davis RJ and Ronai Z: Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 13: 1531-1535, 1996.
25. Musti AM, Treier M and Bohmann D: Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275: 400-402, 1997.
26. Jarvius M, Fryknäs M, D'Arcy P, Sun C, Rickardson L, Gullbo J, Haglund C, Nygren P, Linder S and Larsson R: Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells. Biochem Biophys Res Commun 431: 117-123, 2013.
27. Wang N, Verna L, Hardy S, et al: c-Jun triggers apoptosis in human vascular endothelial cells. Circ Res 85: 387-393, 1999.
28. Podar K, Raab MS, Tonon G, et al: Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma. Cancer Res 67: 1680-1688, 2007.
29. Bossy-Wetzel E, Bakiri L and Yaniv M: Induction of apoptosis by the transcription factor c-Jun. EMBO J 16: 1695-1709, 1997.
30. Teraishi F, Wu S, Zhang L, et al: Identification of a novel synthetic thiazolidin compound capable of inducing c-Jun NH2-terminal kinase-dependent apoptosis in human colon cancer cells. Cancer Res 65: 6380-6387, 2005.
31. Kuntzen C, Sonuc N, De Toni EN, et al: Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. Cancer Res 65: 6780-6788, 2005.
32. Molton SA, Todd DE and Cook SJ: Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3-kinase (PI3K) pathway is inhibited. Oncogene 22: 4690-4701, 2003.